Big news from the Leiden Bio Science Park community: VitroScan has been awarded a ~€200K grant as part of the Medical:Forge Leipzig accelerator. With support from leap:up and a growing network in Saxony, including WIG2 Institut and top oncology centers, VitroScan is laying the groundwork for market access in Germany.
The team is already building ties with local innovators like Healyan and MedicubeX, and exploring Leipzig’s vibrant healthtech scene.
Read more here.
MIMETAS, a leading organ-on-a-chip company, has announced the publication of a new peer-reviewed study that marks a major advance in cardiovascular disease research. The study,...
NecstGen has partnered with Paris-based biotech Astraveus to evaluate the Lakhesys™ Benchtop Cell Factory™, a microfluidic-based platform aiming to simplify and scale CAR-T...
What if you could design something that acts like an antibody, but cheaper, more stable, and made entirely with chemistry? Two LACDR researchers, Sebastian Pomplun and Matthias...